Dow Declares Quarterly Dividend of 46 Cents per Share
Get Alerts DOW Hot Sheet
Join SI Premium – FREE
MIDLAND, Mich.--(BUSINESS WIRE)-- The Dow Chemical Company (NYSE: DOW) has declared a dividend of 46 cents per share, payable July 29, 2016, to shareholders of record on June 30, 2016.
This marks the 419th consecutive cash dividend issued by the Company. Dow has paid its shareholders cash dividends every quarter since 1912.
About Dow
Dow (NYSE: DOW) combines the power of science and technology to passionately innovate what is essential to human progress. The Company is driving innovations that extract value from material, polymer, chemical and biological science to help address many of the world's most challenging problems such as the need for clean water, clean energy generation and conservation, and increasing agricultural productivity. Dow's integrated, market-driven, industry-leading portfolio of specialty chemical, advanced materials, agrosciences and plastics businesses delivers a broad range of technology-based products and solutions to customers in approximately 180 countries and in high-growth sectors such as packaging, electronics, water, coatings and agriculture. In 2015, Dow had annual sales of nearly $49 billion and employed approximately 49,500 people worldwide. The Company's more than 6,000 product families are manufactured at 179 sites in 35 countries across the globe. References to "Dow" or the "Company" mean The Dow Chemical Company and its consolidated subsidiaries unless otherwise expressly noted. More information about Dow can be found at www.dow.com.
®TM Trademark of The Dow Chemical Company (“Dow”) or an affiliated company of Dow
View source version on businesswire.com: http://www.businesswire.com/news/home/20160512005694/en/
The Dow Chemical Company
Rachelle Schikorra
+1 (989) 638-4090
[email protected]
Source: The Dow Chemical Company
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi analyzes positioning in US chemicals stocks
- CoreAgeRx Launches Advanced Preventive Longevity Protocols Featuring Microdosing Semaglutide, Microdosing Tirzepatide, and Sermorelin Therapies
- CoreAge Rx Expands Weight & Metabolic Health Offerings with Affordable, Doctor-Guided Semaglutide and Tirzepatide Programs
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share